annb0t
Top 20
(Adds therapy price)
Nov 22 (Reuters) - A one-time gene therapy for hemophilia B from Australian drugmaker CSL Ltd has been approved by the U.S. Food and Drug Administration, potentially offering a long-term solution for patients with the blood clotting disorder.
The therapy, which will be branded Hemgenix, will be made immediately available in the United States at a list price of $3.5 million, the company said, making it the most expensive therapy in the world.
The approval makes it the firs...
>>> Read more: UPDATE 2-FDA approves CSL's gene therapy for hemophilia
Nov 22 (Reuters) - A one-time gene therapy for hemophilia B from Australian drugmaker CSL Ltd has been approved by the U.S. Food and Drug Administration, potentially offering a long-term solution for patients with the blood clotting disorder.
The therapy, which will be branded Hemgenix, will be made immediately available in the United States at a list price of $3.5 million, the company said, making it the most expensive therapy in the world.
The approval makes it the firs...
>>> Read more: UPDATE 2-FDA approves CSL's gene therapy for hemophilia
